NCT01520324View on ClinicalTrials.gov

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Ulcerative Colitis
Interventions
DEVICE

oral delivery mucosal stain

200mg methylene blue MMX tablet taken prior to colonoscopy

Trial Locations (1)

20089

Centre for Research & Care of Intestinal Diseases, Rozzano

Sponsors
All Listed Sponsors
lead

Cosmo Technologies Ltd

INDUSTRY

NCT01520324 - Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy | Biotech Hunter | Biotech Hunter